alicaforsen enema

August 5, 2019August 5, 2019

Camligo Trial Yields Mixed Results in Patients with Pouchitis

News

Atlantic Healthcare’s Camligo (alicaforsen enema) did not meet the primary endpoints of the Phase 3 clinical trial that aimed to evaluate the efficacy of the drug in patients with pouchitis. ... Read more

May 9, 2018May 9, 2018

Atlantic Healthcare Completes Phase 3 Trial Enrollment for Alicaforsen as Pouchitis Treatment

News

Atlantic Healthcare has completed enrollment for a Phase 3 trial evaluating the safety and efficacy of alicaforsen in patients with pouchitis, a frequent complication after surgery to treat different forms ... Read more

February 23, 2016February 23, 2016

Topical Treatment for Inflammatory Bowel Disease Pouchitis Starts Pivotal Phase 3 Trial, Now Enrolling Patients

News

Atlantic Healthcare plc announced that it is now enrolling patients in a Phase 3 clinical trial to assess alicaforsen enema for the treatment of inflammatory bowel disease (IBD) pouchitis. Pouchitis, the inflammation of ... Read more